Antimicrobial susceptibility and analysis of macrolide resistance genes in Streptococcus pneumoniae isolated in Hamadan

Document Type: Original Article

Authors

1 Department of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

2 Department of Molecular Medicine and Genetics, Hamadan University of Medical Sciences, Hamadan, Iran

3 Human and Animal Cell Bank, Iranian Biological Resource center (IBRC), ACECR, Tehran, Iran

Abstract

Objective(s): Macrolide resistant Streptococcus pneumoniae pose an emerging problem globally. The aim of this study was to investigate the prevalence of ermB and mefA genes (macrolide resistant genes) by polymerase chain reaction (PCR) method and to detect drug resistance patterns of S. pneumoniae isolated from clinical samples to macrolides and other antibiotic agents by E-test method.
Materials and Methods: Fifty five isolates of S. pneumoniae were obtained from clinical samples with microbial tests. The antibiotic susceptibility of isolates for erythromycin, azithromycin, clarithromycin, ceftazidime, ciprofloxacin and vancomycin were determined by E-test method. Genotypic antibiotic resistance pattern was determined by PCR with primer designed for ermB and mefA genes.
Results: The number of S. pneumoniae isolates resistance to erythromycin, azithromycin, clarithromycin, ceftazidim, ciprofloxacin were 25.5%, 18.2%, 16.4%, 21.8% and 10.9%, respectively while no resistance to vancomycin was observed. The macrolide resistance genes of ermB and mefA were found in 10.9% and 18.2% of the isolates, respectively.
Conclusion: The result of the current study suggests the necessity of evaluation the changes in MIC[FA1] [a2]  (minimum inhibitory concentration) values as well as genetic mutations to estimate the prevalence of the resistance antimicrobial agents in S. pneumoniae.

Keywords


1.Van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009; 374:1543-1556.

2.Zignol M, van Gemert W, Falzon D, Jaramillo E, Blanc L, Raviglione M. Modernizing surveillance of anti-tuberculosis drug resistance: from special surveys to routine testing. Clin Infect Dis 2011; 52:901–906.

3.Song JH, Chang HH, Suh JY, Ko KS, Jung SI, Oh WS,            et al. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian Countries: ANSORP Study. J AntimicrobChemother 2004; 53:457-463.

4.Littauer P, Sangvik M, Caugant DA, Hoiby EA, Simonsen GS, Sundsfjord A, et al. Molecular epidemiology of macrolide-resistant isolates of Streptococcus pneumoniae collected from blood and respiratory specimens in Norway. J Clin Microbiol 2005; 43:2125-2132.

5.Garau J. Treatment of drug-resistant pneumococcal pneumonia. Lancet Infect Dis 2002; 2:404-415.

6.Harwell JI, Brown RB. The drug-resistant pneumococcus: clinical relevance, therapy, and prevention. Chest 2000; 117:530-541.

7.Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppala H. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 1999; 43:2823-2830.

8.Tait-Kamradt A, Davies T, Appelbaum PC, Depardieu F, Courvalin P, Petitpas J, et al. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob Agents Chemother 2000; 44:3395-3401.

9.Edelstein PH. Pneumococcal resistance to macrolides, lincosamides, ketolides, and streptogramin B agents: molecular mechanisms and resistance phenotypes. Clin Infect Dis 2004; 38:S322–327.

10.Reinert RR, Filimonova OY, Al-Lahham A, Grudinina SA, Llina EN, Weigel LM, et al. Mechanisms of macrolide resistance among Streptococcus pneumoniae isolates from Russia. Antimicrob Agents Chemother 2008; 52:2260-2262.

11.Tait-Kamradt A, Davies T, Cronan M, Jacobs MR, Appelbaum PC, Sutcliffe J. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob Agents Chemother 2000; 44:2118-2125.

12.Ubukata K, Muraki T, Igarashi A, Asahi Y, Konno M. Identification of penicillin and other beta lactam Resistance in Streptococcus pneumoniae by polymerase chain reaction. J Infect Chemother 1997; 3:190-197.

13.Ubukata K, Asahi Y, Yamane Y, Konno M. Combinational detection of autolysin and pencillin-binding protein 2B genes of Streptococcus pneumoniae by PCR. J Clin Microbial 1996; 34:592-596.

14.García P, García JL, García E, López R. Nucleotide sequence and expression of the pneumococcal autolysin gene from its own promoter in Escherichia coli. Gene 1986; 43:265-272.

15.Jorgensen JH, Howell AW, Maher LA. Quantitative antimicrobial susceptibility testing of haemophilusinfluenzae and Streptococcus pneumoniae by Using the E-Test. J ClinMicrobiol 1991; 29:109–114.

16.Baker CN, Stocker SA, Culver DH, Thornsberry C. Comparsion of the E-Test to agar dillution, broth microdillution,and agar diffusion susceptibility testingtechniques by using a special challenge set of bacteria. J Clin Microbiol 1991; 29:533–538.

17.Ubukata K, Iwata S, Sunakawa K. In vitro activity of new ketolide, telithromycin, and eight other macrolide antibiotics against Streptococcus pneumoniae having mefA and ermB genes that mediate macrolide resistance. J Infect Chemother 2003; 9: 221-226.

18.Jorgensen JH, Maher LA, Howell AW. Use of Haemophilus test medium for broth microdilution. antimicrobial susceptibility testing of Streptococcus pneumoniae. J ClinMicrobiol 1990; 28:430–434.

19.National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Disk Susceptibility Test: Approved Standards. 4th ed. Villanova, PA: NCCLS; 2001.

20.Farajnia S, Azhari F, Alikhani MY, Hosseini MK, Peymani A, Sohrabi N. Prevalence of PER and VEB type extended spectrum betalactamases among multidrug resistant acinetobacter baumannii isolates in north-west of Iran. Iran J Basic Med Sci 2013; 16:751–755.

21.Zamani A, Yousefi Mashouf R, Ebrahimzadeh Namvar AM, Alikhani MY. Detection of magA gene in Klebsiella spp. isolated from clinical samples detection of magA. Iran J Basic Med Sci 2013; 16: 173-176.

22. Pourahmad Jaktaji R, Jazayeri N. Expression of acrA and acrB genes in esherichia coli mutants with or without marR or acrR mutations. Iran J Basic Med Sci 2013; 16:1254–1258.

23.Ubukata K, Chiba N, Hasegawa K, Kobayashi R, Iwata S, Sunakawa K. Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of strains responsible for meningitis in Japan, 1999 to 2002. Antimicrob Agents Chemother 2004; 48:1488–1494.

24.Karlowsky JA, Thornsberry C, Jones ME, Evangelista AT, Critchley IA, Sahm DF, et al. Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST surveillance program (1998–2002). Clin Infect Dis 2003; 36:963–970.

25.Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000; 343:1917-1924.

26.Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med 1999; 341:233-239.

27.Davidson R, Cavalcanti R, Brunton JL, Bast DJ, de Azavedo JCS, Kibsey P, et al. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med 2002; 346:747–750.

28.Noguchi N, Tano J, Nasu Y, Koyama M, Narui K, Kamishima H, et al. Antimicrobial susceptibilities and distribution of resistance genes for beta-lactams and macrolides in Streptococcus pneumoniae isolated between 2002 and 2004 in Tokyo. Int J Antimicrob Agents 2007; 29:26-33.

29.Okamoto H, Tateda K, Ishii Y, Matsumoto T, Kobayashi T, Miyazaki S, et al. High frequency of erythromycin A resistance and distribution of mefE and ermB genes in clinical isolates of Streptococcus pneumoniae in Japan. J Infect Chemother 2002; 8:28–32.

 30.Hiramatsu K, Ohama M, Mijajima Y, Kishi K, Mizunoe S, Tokimatsu I, et al. Antimicrobial susceptibilities and analysis of genes related to penicillin or macrolide resistance in Streptococcus pneumoniae. Int J Antimicrob Agents 2004; 24:125-129.